MolNFT v1 · #132318 · protein
T. brucei fpps in complex with cid 126782062
5QTG · Farnesyl pyrophosphate synthase: “T. brucei fpps in complex with cid 126782062”. X-ray diffraction, 3 ligands (PK4, NA, PO4), 3 pockets (best druggability 0.66). MolNFT v1 #132318 on GenesisL1: 3D structure, binding sites and…
- PDB
- 5QTG
- Type
- protein
- Length
- 330 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Farnesyl pyrophosphate synthase
- UniProt
- Q86C09
- Ligands
- PK4, NA, PO4
- Pockets
- 3 · best druggability 0.66
Structure
x-ray diffraction · 1 distinct chain · 78% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Farnesyl pyrophosphate synthase | protein | 330 | 78% helix, 0% strand | Q86C09 |
Ligands and binding sites
- PK4 · 2-fluoro-N,3-dimethylbenzene-1-sulfonamide · ligand · chains A
- NA · Sodium ion · metal · chains A
- PO4 · Phosphate ion · ion · 2 copies · chains A
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 604 | 0.66 | 0.76 | 50 | NA, PO4, GOL |
| 2 | 90 | 0.46 | 0.80 | 14 | PK4 |
| 3 | 76 | 0.35 | 0.76 | 22 | empty |
Compared structures
- 5QTG · T. brucei FPPS in complex with CID 126782062 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q86C09
- Elsewhere: RCSB PDB 5QTG · PDBe 5QTG · UniProt Q86C09
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.